TickerFacts.

Company research / UTMD

Utah Medical Products Inc (UTMD)

Build a valuation ↗↓ Download CSV

SEC name UTAH MEDICAL PRODUCTS INC · CIK 0000706698 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated UT
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Utah Medical Products Inc reported revenue of $38.52M. Revenue fell 5.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $36.11M.

Key ratios (year ended 2025-12-31)

57.1%
Gross margin
29.6%
Operating margin
29.3%
Net margin
9.5%
Return on year-end equity
-5.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-22

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$36.11M$38.52M$40.90M$50.22M$52.28M$49.05M$42.18M$46.90M$42.00M$41.41M$39.30M
Cost of Revenue$15.20M$16.52M$16.76M$20.19M$20.09M$18.14M$16.63M$17.44M$15.69M$15.02M$15.61M
Gross Profit$20.91M$22.00M$24.14M$30.04M$32.20M$30.92M$25.55M$29.47M$26.31M$26.39M$23.69M
R&D Expense$687.0K$668.0K$813.0K$560.0K$493.0K$526.0K$486.0K$483.0K$454.0K$447.0K$475.0K
Operating Income$10.27M$11.40M$13.59M$16.78M$19.79M$18.88M$13.71M$17.63M$18.70M$19.01M$16.19M
Net Income$10.49M$11.29M$13.87M$16.64M$16.47M$14.79M$10.80M$14.73M$18.55M$8.51M$12.13M
EPS (Diluted)n/a$3.48$3.96$4.57$4.52$4.04$2.94$3.94$4.95$2.28$3.22
Total Assets$124.57M$122.54M$122.54M$135.46M$123.87M$115.64M$111.75M$109.79M$99.77M$92.75M$76.19M
Total Liabilities$2.54M$3.27M$5.11M$7.14M$9.62M$8.50M$8.92M$8.69M$10.78M$14.62M$6.95M
Long-Term Debtn/a$0$0$0$0$0$0$0$0$0n/a
Shareholders' Equity$122.03M$119.27M$117.43M$128.31M$114.25M$107.14M$102.82M$101.09M$88.99M$78.12M$69.24M
Cash & Equivalents$87.53M$85.76M$82.98M$92.87M$75.05M$60.97M$51.59M$42.79M$51.11M$39.88M$26.30M
Operating Cash Flow$11.85M$14.69M$14.83M$22.28M$21.15M$21.20M$20.14M$17.06M$16.83M$16.91M$14.53M
Capital Expenditures$400.0K$371.0K$230.0K$639.0K$809.0K$552.0K$860.0K$540.0K$402.0K$1.60M$3.29M
Free Cash Flow$11.45M$14.32M$14.60M$21.64M$20.34M$20.65M$19.28M$16.52M$16.43M$15.31M$11.23M
Share Repurchases$1.85M$8.36M$19.97M$0$2.50M$0$6.98M$398.0K$1.21M$0n/a
Dividends Paid$3.94M$3.98M$4.26M$4.28M$3.16M$11.46M$4.12M$4.11M$4.03M$2.96M$3.92M
Shares Outstanding3.18M3.19M3.33M3.63M3.63M3.65M3.64M3.72Mn/a3.72M3.71M
Weighted Average Diluted Sharesn/a3.24M3.50M3.64M3.64M3.66M3.67M3.74M3.75M3.74M3.77M
EPS (Basic)n/a$3.48$3.96$4.58$4.53$4.05$2.95$3.96$4.97$2.29$3.23

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView